Wells Fargo & Company »

Intellia Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.9M 216k 27.51
2023-12-31 $6.2M 203k 30.49
2023-09-30 $7.2M 227k 31.57
2023-06-30 $7.6M 187k 40.78
2022-12-31 $2.4M 70k 34.89
2022-09-30 $7.5M 135k 55.67
2022-06-30 $3.9M 75k 51.77
2022-03-31 $7.2M 99k 72.66
2021-12-31 $15M 129k 118.55
2021-09-30 $17M 129k 134.14
2021-06-30 $19M 115k 161.93
2021-03-31 $10M 126k 80.26
2020-12-31 $8.4M 155k 54.41
2020-09-30 $1.3M 67k 19.88
2020-06-30 $2.3M 110k 21.00
2020-03-31 $986k 81k 12.21
2019-12-31 $906k 62k 14.65
2019-09-30 $737k 55k 13.36
2019-06-30 $855k 52k 16.37
2019-03-31 $792k 46k 17.07
2018-12-31 $461k 34k 13.63
2018-09-30 $1.8M 63k 28.61
2018-06-30 $2.0M 71k 27.34
2018-03-31 $1.7M 79k 21.06
2017-12-31 $669k 35k 19.23
2017-06-30 $482k 30k 15.96
2017-03-31 $154k 11k 14.04
2016-12-31 $43k 3.3k 12.92
2016-09-30 $41k 2.4k 17.08
2016-06-30 $51k 2.4k 21.25